TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV) – Here’s Why

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best healthcare stocks under $50 to invest in. TD Cowen maintained a bullish outlook on Roivant Sciences Ltd. (NASDAQ:ROIV) on February 6, revising the price target on the stock to $38 from $28 and maintaining a Buy rating. The rating update came the same day Roivant Sciences Ltd. (NASDAQ:ROIV) announced positive Phase 2 results for brepocitinib in cutaneous sarcoidosis (CS) and reported its financial results for Q3 ended December 31, 2025. WhyRoivant Scie ...